Latest news
Loading news…
CNS Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Saint Paul, Minnesota, United States Founded 2007 51-100 employees For Profit
CNS Therapeutics develops pharmaceuticals for the treatment of neurological disorders and chronic pain.
CNS Therapeutics was acquired by Mallinckrodt in 2012 for $100M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Active products
- 1
Company Info
- Founded
- 2007
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 6
- HQ
- Saint Paul, Minnesota, United States
- Region
- Greater Minneapolis-Saint Paul Area, Great Lakes, Midwestern US
- Exit date
- Sep 24, 2012
- Closed
- Feb 22, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.9
- Trend (90d)
- 0
1
professional contacts at CNS Therapeutics
Contact execs at CNS Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CNS Therapeutics
Loading news…
FAQs about CNS Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.